FGEN NASDAQ

FibroGen, Inc - Common Stock

Healthcare · Biotechnology
$7.05
▲ +$0.17 (+2.47%)
Vol 36K
6
Quality Score
fail
Mkt Cap
$35.5M
P/E
0.2
ROE
-290.9%
Margin
2598.9%
D/E
58.56
Beta
0.84
52W
$5–$22

Price Chart

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) — -290.9% -290.9% -290.9% -290.9% -290.9%
P/E (TTM) — — — — 0.15 0.16
Net Margin -564.0% -9.7% -3.9% -3.9% 2598.9% 2598.9%
Gross Margin 93.7% 109.7% 128.1% 128.1% 345.7% 345.7%
D/E Ratio — 58.56 58.56 58.56 58.56 58.56
Current Ratio 1.04 2.02 1.04 1.04 3.71 3.71

Key Ratios

ROA (TTM)
124.2%
P/S (TTM)
4.28
P/B
6.3
EPS (TTM)
$53.34
CF/Share
$-2.97
Rev Growth 3Y
-49.9%
52W High
$21.94
52W Low
$4.85
$4.85 52-Week Range $21.94

How does FGEN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

FGEN AAPG ABEO ABOS ABP

FGEN valuation vs Biotechnology peers

P/E ratio
0.2
▼ 99% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
4.3
▼ 67% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
6.3
▲ 154% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

FGEN profitability vs Biotechnology peers

ROE
-290.9%
▼ 332% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
2598.9%
▲ 1006% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
345.7%
▲ 340% above peers (78.6%)
vs Peers
vs Industry
Below avg
ROA
124.2%
▲ 366% above peers (-46.7%)
vs Peers
vs Industry
Top tier

FGEN financial health vs Biotechnology peers

D/E ratio
58.6
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
3.7
▼ 16% below peers (4.4)
vs Peers
vs Industry
Below avg
Beta
0.8
▼ 13% below peers (1.0)
vs Peers
vs Industry
Less volatile

FGEN fundamentals radar

FGEN Peer median Industry

FGEN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

FGEN vs peers: key metrics

Latest News

No related news yet